Business
Amai Proteins welcomes new CEO
Brown succeeds Amir Guttman, PhD, who is transitioning to an executive board member role.
Brown joins the company from Sirio Pharma, where he was most recently vice president, head of global account management and earlier general manager of Americas.
He also was previously chief commercial officer at Best Formulations, a division of Sirio Pharma and earlier was CCO at Clasado Biosciences.
Guttman, who had been CEO since July 2025, joined Amai in 2018 as a board member.
Amai’s flagship product is sweelin, a monellin-based sweet protein that is produced through precision fermentation that may be used in such applications as food and beverages, confectionery, chewing gum, condiments and dietary supplements.
Enjoying this content? Learn about more disruptive startups on the Food Entrepreneur page.
You must be logged in to post a comment Login